Outdoor LED panel of a stock graph
Markets

HealthInvest Partners AB Buys Gilead Sciences Inc, McKesson Corp, Syneron Medical Ltd, Sells ...

HealthInvest Partners AB

  • New Purchases: GILD , MCK , ELOS , ATEC,
  • Reduced Positions:ANIK, GNC, MRK, ANTM, ABC, GTS, CAH, CRL, SUPN, TARO,
  • Sold Out:AMAG, LPNT, CXRX, INCR, INSY, OSUR,

For the details of HealthInvest Partners AB's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=HealthInvest+Partners+AB

These are the top 5 holdings of HealthInvest Partners AB

  1. Supernus Pharmaceuticals Inc ( SUPN ) - 538,241 shares, 12.52% of the total portfolio. Shares reduced by 18.14%
  2. Anika Therapeutics Inc ( ANIK ) - 175,967 shares, 7.94% of the total portfolio. Shares reduced by 57.35%
  3. Cardinal Health Inc ( CAH ) - 117,800 shares, 7.81% of the total portfolio. Shares reduced by 26.38%
  4. Charles River Laboratories International Inc ( CRL ) - 111,112 shares, 7.8% of the total portfolio. Shares reduced by 25.73%
  5. AmerisourceBergen Corp ( ABC ) - 107,000 shares, 7.71% of the total portfolio. Shares reduced by 33.13%

New Purchase: Gilead Sciences Inc (GILD)

HealthInvest Partners AB initiated holdings in Gilead Sciences Inc. The purchase prices were between $71.61 and $78.47, with an estimated average price of $74.33. The stock is now traded at around $70.69. The impact to the portfolio due to this purchase was 7.46%. The holdings were 113,000 shares as of 2016-12-31.

New Purchase: McKesson Corp (MCK)

HealthInvest Partners AB initiated holdings in McKesson Corp. The purchase prices were between $124.11 and $165.82, with an estimated average price of $147.1. The stock is now traded at around $149.32. The impact to the portfolio due to this purchase was 7.38%. The holdings were 57,000 shares as of 2016-12-31.

New Purchase: Syneron Medical Ltd (ELOS)

HealthInvest Partners AB initiated holdings in Syneron Medical Ltd. The purchase prices were between $7.05 and $8.85, with an estimated average price of $7.84. The stock is now traded at around $8.70. The impact to the portfolio due to this purchase was 5.46%. The holdings were 706,107 shares as of 2016-12-31.

New Purchase: Alphatec Holdings Inc (ATEC)

HealthInvest Partners AB initiated holdings in Alphatec Holdings Inc. The purchase prices were between $3.21 and $8.22, with an estimated average price of $5.42. The stock is now traded at around $3.24. The impact to the portfolio due to this purchase was 1.26%. The holdings were 426,855 shares as of 2016-12-31.

Sold Out: AMAG Pharmaceuticals Inc (AMAG)

HealthInvest Partners AB sold out the holdings in AMAG Pharmaceuticals Inc. The sale prices were between $23.19 and $36.05, with an estimated average price of $29.88.

Sold Out: LifePoint Health Inc (LPNT)

HealthInvest Partners AB sold out the holdings in LifePoint Health Inc. The sale prices were between $52.55 and $61.75, with an estimated average price of $57.85.

Sold Out: Concordia International Corp (CXRX)

HealthInvest Partners AB sold out the holdings in Concordia International Corp. The sale prices were between $1.83 and $5.17, with an estimated average price of $3.06.

Sold Out: INC Research Holdings Inc (INCR)

HealthInvest Partners AB sold out the holdings in INC Research Holdings Inc. The sale prices were between $41.45 and $52.6, with an estimated average price of $48.41.

Sold Out: Insys Therapeutics Inc (INSY)

HealthInvest Partners AB sold out the holdings in Insys Therapeutics Inc. The sale prices were between $9.07 and $14.53, with an estimated average price of $11.3.

Sold Out: OraSure Technologies Inc (OSUR)

HealthInvest Partners AB sold out the holdings in OraSure Technologies Inc. The sale prices were between $7.1 and $9.37, with an estimated average price of $8.26.

Reduced: Anika Therapeutics Inc ( ANIK )

HealthInvest Partners AB reduced to the holdings in Anika Therapeutics Inc by 57.35%. The sale prices were between $41.44 and $50.02, with an estimated average price of $46.23. The stock is now traded at around $49.84. The impact to the portfolio due to this sale was -5.82%. HealthInvest Partners AB still held 175,967 shares as of 2016-12-31.

Reduced: GNC Holdings Inc (GNC)

HealthInvest Partners AB reduced to the holdings in GNC Holdings Inc by 37.98%. The sale prices were between $10.84 and $21.68, with an estimated average price of $15.65. The stock is now traded at around $9.22. The impact to the portfolio due to this sale was -2.89%. HealthInvest Partners AB still held 422,955 shares as of 2016-12-31.

Reduced: Merck & Co Inc (MRK)

HealthInvest Partners AB reduced to the holdings in Merck & Co Inc by 39.27%. The sale prices were between $58.43 and $64.96, with an estimated average price of $61.33. The stock is now traded at around $61.81. The impact to the portfolio due to this sale was -2.32%. HealthInvest Partners AB still held 136,100 shares as of 2016-12-31.

Reduced: Anthem Inc (ANTM)

HealthInvest Partners AB reduced to the holdings in Anthem Inc by 40.04%. The sale prices were between $117.42 and $147.66, with an estimated average price of $133.9. The stock is now traded at around $150.16. The impact to the portfolio due to this sale was -2.27%. HealthInvest Partners AB still held 56,300 shares as of 2016-12-31.

Reduced: AmerisourceBergen Corp ( ABC )

HealthInvest Partners AB reduced to the holdings in AmerisourceBergen Corp by 33.13%. The sale prices were between $69.03 and $81.33, with an estimated average price of $78.02. The stock is now traded at around $84.88. The impact to the portfolio due to this sale was -1.93%. HealthInvest Partners AB still held 107,000 shares as of 2016-12-31.

Reduced: Triple-S Management Corp (GTS)

HealthInvest Partners AB reduced to the holdings in Triple-S Management Corp by 31.66%. The sale prices were between $19 and $23.68, with an estimated average price of $21.87. The stock is now traded at around $19.64. The impact to the portfolio due to this sale was -1.89%. HealthInvest Partners AB still held 364,156 shares as of 2016-12-31.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIK SUPN ABC CRL CAH

Other Topics

Stocks

Latest Markets Videos